278 related articles for article (PubMed ID: 8097952)
1. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
Renesto P; Chignard M
Blood; 1993 Jul; 82(1):139-44. PubMed ID: 8324217
[TBL] [Abstract][Full Text] [Related]
3. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
4. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
[TBL] [Abstract][Full Text] [Related]
5. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
Renesto P; Chignard M
J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
Renesto P; Balloy V; Chignard M
Eur J Pharmacol; 1993 Aug; 248(2):151-5. PubMed ID: 8223961
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
Renesto P; Chignard M
J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro.
Masuda K; Kamimura T; Watanabe K; Suga T; Kanesaki M; Takeuchi A; Imaizumi A; Suzuki Y
Br J Pharmacol; 1995 Jul; 115(6):883-8. PubMed ID: 7582515
[TBL] [Abstract][Full Text] [Related]
10. Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli.
Masuda K; Kamimura T; Kanesaki M; Ishii K; Imaizumi A; Sugiyama T; Suzuki Y; Ohtsuka E
Protein Eng; 1996 Jan; 9(1):101-6. PubMed ID: 9053897
[TBL] [Abstract][Full Text] [Related]
11. Plasma antiproteinase screen and neutrophil-mediated platelet activation. A major role played by alpha 1 antitrypsin.
Chignard M; Hazouard E; Renesto P; Laine A; Guidet B; Offenstadt G
Biochim Biophys Acta; 1994 Dec; 1224(3):433-40. PubMed ID: 7803500
[TBL] [Abstract][Full Text] [Related]
12. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
Evangelista V; Rajtar G; de Gaetano G; White JG; Cerletti C
Blood; 1991 Jun; 77(11):2379-88. PubMed ID: 1645603
[TBL] [Abstract][Full Text] [Related]
14. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G.
Bangalore N; Travis J
Biol Chem Hoppe Seyler; 1994 Oct; 375(10):659-66. PubMed ID: 7888078
[TBL] [Abstract][Full Text] [Related]
15. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
Ferrer-Lopez P; Renesto P; Prevost MC; Gounon P; Chignard M
J Lab Clin Med; 1992 Mar; 119(3):231-9. PubMed ID: 1541873
[TBL] [Abstract][Full Text] [Related]
16. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva.
Masuda K; Suga T; Takeuchi A; Kanesaki M; Imaizumi A; Suzuki Y
Biochem Pharmacol; 1994 Aug; 48(4):651-7. PubMed ID: 8080437
[TBL] [Abstract][Full Text] [Related]
17. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
18. Synergism between interleukin-8 and tumor necrosis factor-alpha for neutrophil-mediated platelet activation.
Si Tahar M; Renesto P; Balloy V; Chignard M
Eur Cytokine Netw; 1994; 5(5):455-60. PubMed ID: 7880976
[TBL] [Abstract][Full Text] [Related]
19. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
Bergenfeldt M; Axelsson L; Ohlsson K
Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620
[TBL] [Abstract][Full Text] [Related]
20. Proteinase 3. A neutrophil proteinase with activity on platelets.
Renesto P; Halbwachs-Mecarelli L; Nusbaum P; Lesavre P; Chignard M
J Immunol; 1994 May; 152(9):4612-7. PubMed ID: 8157974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
